Pathogenesis and prediction of diabetes mellitus: Lessons from integrative physiology

Mount Sinai Journal of Medicine

Volumn 69, Issue 5, 2002, Pages 280-290

  Bergman, Richard N ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

cell; Insulin resistance; Minimal model; Modeling

Indexed keywords

FATTY ACID; INSULIN; INULIN;

ADIPOSE TISSUE; ARTICLE; BLOOD GLUCOSE MONITORING; CAPILLARY ENDOTHELIUM; CONTROLLED STUDY; DIABETES MELLITUS; DRUG BLOOD LEVEL; GLUCONEOGENESIS; GLUCOSE TRANSPORT; INSULIN RELEASE; INSULIN RESISTANCE; MATHEMATICAL MODEL; METABOLIC REGULATION; NONHUMAN; PATHOGENESIS; PROGNOSIS; QUANTITATIVE ANALYSIS; REGULATORY MECHANISM; RISK ASSESSMENT;

ANIMALS; DIABETES MELLITUS, TYPE 2; FATTY ACIDS, NONESTERIFIED; GLUCOSE; HUMANS; INSULIN RESISTANCE; ISLETS OF LANGERHANS; MODELS, BIOLOGICAL; OBESITY;

EID: 0036772294     PISSN: 00272507     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (59)

1. Schwartz IL, Hechter O. Insulin structure and function: reflections on the present state of the problem. Am J Med 1965; 40:765-772.
2. Bergman RN, Hechter O. A random-hit matrix model for coupling in a hormone-sensitive adenylate cyclase system. J Biol Chem 1978; 253:3238-3250.
3. Collins FS. Contemplating the end of the beginning. Genome Res 2001; 11:641-643.
4. Bruning JC, Michael MD, Winnay JN, et al. A muscle-specific insulin receptor knockout exhibits features of the metabolic syndrome of NIDDM without altering glucose tolerance. Molec Cell 1998; 2:559-569.
5. Nakae J, Kido Y, Accili D. Tissue-specific insulin resistance in type 2 diabetes: lessons from gene-targeted mice. Ann Med 2001; 33:22-27.
6. Bergman RN. Toward physiological understanding of glucose tolerance: minimal-model approach (Lilly Lecture). Diabetes 1989; 38:1512-1527.
7. Bergman RN, Ider YZ, Bowden CR, Cobelli C. Quantitative estimation of insulin sensitivity. Am J Physiol 1979; 236:E667-E677.
8. Bergman RN. The minimal model: yesterday, today and tomorrow. In: Bergman RN, Lovejoy JC, editors. The minimal model approach and determination of glucose tolerance. Baton Rouge (LA): LSU Press; 1997. pp. 3 - 50.
9. Finegood DT. Application of the minimal model of glucose kinetics. In: Bergman RN, Lovejoy JC, editors. The minimal model approach and determinants of glucose tolerance. Baton Rouge (LA): LSU Press; 1997. pp. 51-122.
10. Bolie VW. Coefficients of normal blood glucose regulation. J Appl Physiol 1961; 16:783-788.
11. Srinivasan R, Kadish A, Shridar R. A mathematical model for the control mechanisms of free fatty acid-glucose metabolism in normal humans. Comput Biomed Res 1970; 3:146-166.
12. Grodsky GM. A threshold distribution hypothesis for packet storage of insulin and its mathematical modeling. J Clin Invest 1972; 51:2047-2059.
13. Bergman RN. The minimal model of glucose regulation: a biography. In: Novotny J, Green M, Boston R, editors. Mathematical modeling in nutrition and health. New York: Kluwer Academic/Plenum Publishers; 2001.
14. Rasio EA, Mack E, Egdahl RH, Herrera MG. Passage of insulin and inulin across vascular membranes in the dog. Diabetes 1968; 17:668-672.
15. Rasio EA, Hill GJ, Soeldner JS, Herrera MG. Effect of pancreatectomy on glucose tolerance and extracellular fluid insulin in the dog. Diabetes 1967; 16:551-556.
16. Sherwin RS, Kramer KJ, Tobin JD, et al. A model of the kinetics of insulin in man. J Clin Invest 1974; 53:1481-1492.
17. Insel PA, Liljenquist JE, Tobin JD, et al. Insulin control of glucose metabolism in man. J Clin Invest 1975; 55:1057-1066.
18. King GL, Johnson SM. Receptor-mediated transport of insulin across endothelial cells. Science 1985; 227:1583-1586.
19. Jialal I, King GL, Buchwald S, et al. Processing of insulin by bovine endothelial cells in culture: internalization without degradation. Diabetes 1984; 33:794-800.
20. Yang YJ, Hope ID, Ader M, Bergman RN. Insulin transport across capillaries is rate limiting for insulin action in dogs. J Clin Invest 1989; 84:1620-1628.
21. Yang YJ, Hope ID, Ader M, et al. Dose response relationship between lymph insulin and glucose uptake reveals enhanced insulin sensitivity of peripheral tissues. Diabetes 1992; 41:241-253.
22. Hamilton-Wessler M, Ader M, Dea M, et al. Mechanism of protracted metabolic effects of fatty acid acylated insulin, NN304, in dogs: retention of NN304 by albumin. Diabetologia 1999; 42:1254-1263.
23. Hamilton-Wessler M, Ellmerer M, Dea MK, et al. Insulin resistance in dogs with transendothelial transport defect [abstract]. Diabetes 2000; 49(Suppl 1):A59.
24. Jensen I, Kruse V, Larsen UD. Scintigraphic studies in rats: kinetics of insulin analogues covering wide range of receptor affinities. Diabetes 1991; 40:628-632.
25. Bradley DC, Poulin RA, Bergman RN. Dynamics of hepatic and peripheral insulin effects suggest common rate-limiting step in vivo. Diabetes 1992; 42:296-306.
26. Rebrin K, Steil GM, Getty L, Bergman RN. Free fatty acid as a link in the regulation of hepatic glucose output by peripheral insulin. Diabetes 1995; 44:1038-1045.
27. Rebrin K, Steil GM, Mittelman S, Bergman RN. Causal linkage between insulin suppression of lipolysis and supression of liver glucose output in dogs. J Clin Invest 1996; 98:741-749.
28. Hamilton-Wessler M, Bergman RN. Acute elevations in free fatty acids cause equivalent reversal of insulin effect on liver and periphery [abstract]. Diabetes 1999; 48(Suppl 1):A278.
29. Xiang A, Peters RK, Trigo E, et al. Multiple metabolic defects during late pregnancy in women at high risk for type 2 diabetes mellitus. Diabetes 1999; 48:848-854.
30. Bergman RN. New concepts in extracellular signaling for insulin action: the single gateway hypothesis. Rec Progr Horm. Res 1997; 42:359-385.
31. Bergman RN, Mittelman SD. Central role of the adipocyte in insulin resistance. J Basic Clinical Physiol Pharmacol 1998; 9:205-221.
32. Haffner SM, Stern MP, Hazuda HP, et al. Role of obesity and fat distribution in non-insulin-dependent diabetes mellitus in Mexican Americans and non-Hispanic whites. Diab Care 1986; 9:153-161.
33. Larsson B, Bengtsson C, Bjorntorp P, et al. Is abdominal body fat distribution a main explanation for the sex difference in the incidence of myocardial infarction? Am J Epidemiol 1993; 135:266-273.
34. Lillioja S, Bogardus C. Obesity and insulin resistance: lessons learned from the Pima Indians. Diab Metab Rev 1988; 5:517-540.
35. Carey DG, Jenkins AB, Campbell LV, et al. Abdominal fat and insulin resistance in normal and overweight women: direct measurements reveal a strong relationship in subjects at both low and high risk of NIDDM. Diabetes 1996; 45:633-638.
36. Mittelman SD, van Citters GW, Kim SP, et al. The longitudinal compensation for fat induced insulin resistance includes reduced insulin clearance and enhanced β-cell response. Diabetes 2000; 49:2116-2125.
37. Rocchini AP, Marker P, Cervenka T. Time course of insulin resistance associated with feeding dogs a high-fat diet. Am J Physiol 1997; 272:E147-EI54.
38. Kaiyala K, Prigeon RL, Kahn SE, et al. Reduced β-cell function contributes to impaired glucose tolerance in dogs made obese by high-fat feeding. Am J Physiol 1999; 277:E659-E667.
39. Kabir M, Dea MK, Mittelman SD. Changes in receptor number account for decreased insulin clearance in fat fed dogs [abstract]. Diabetes 2000; 49(Suppl 1):A285.
40. Richey JM, Freed HS, Bergman RN. Dissociation between insulin's effects to suppress plasma FFA and endogenous glucose production in high fat fed rats [abstract]. Diabetes 2001; 50(Suppl 2):A325.
41. Kim SP, Ellmerer M, van Citters GW, Bergman RN. Predominance of hepatic insulin resistance in the fat-fed dog with visceral adiposity. J Invest Mod 2002; [in press].
42. Zierath JR, Livingston JN, Thorne A, et al. Regional differences in insulin inhibition of non-esterified fatty acid release from human adipocytes: relation to insulin receptor phosphorylation and intracellular signalling through the insulin receptor substrate-1 pathway. Diabetologia 1998; 41:1343-1354.
43. Mittelman SD, van Citters GW, Kirkman EL, Bergman RN. Extreme insulin resistance of the central adipose depot in vivo. Diabetes In press.
44. Steppan CM, Bailey ST, Bhat S, et al. The hormone resistin links obesity to diabetes. Nature 2001; 409:307-312.
45. Yamauchi T, Kamon J, Waki H, et al. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nature Med 2001; 7:941-946.
46. Porte D, Jr. β-cells in type II diabetes mellitus (Banting Lecture). Diabetes 1991; 40:166-180.
47. DeFronzo RA. The triumvirate: β-cell, muscle, liver. A collusion responsible for NIDDM. Lilly Lecture. Diabetes 1988; 37:667-687.
48. Reaven GM. Role of insulin resistance in human disease (Banting Lecture). Diabetes 1988; 37:1595-1607.
49. Yalow RS, Glick SM, Roth J, Berson SA. Plasma insulin and growth hormone levels in obesity and diabetes. Ann N Y Acad Sci 1965; 131:357-373.
50. Perley M, Kipais DM. Plasma insulin responses to glucose and tolbutamide of normal weight and obese diabetic and nondiabetic subjects. Diabetes 1966; 15:867-874.
51. Bergman RN, Phillips LS, Cobelli C. Physiologic evaluation of factors controlling glucose tolerance in man: measurement of insulin sensitivity and β-cell glucose sensitivity from the response to intravenous glucose. J Clin Invest 1981; 68:1456-1467.
52. DeFronzo RA, Tobin JD, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 1979; 237:E214-E223.
53. Halter JB, Graf RJ, Porte D, Jr. Potentiation of insulin secretory responses by plasma glucose levels in man: evidence that hyperglycemia in diabetes compensates for impaired glucose potentiation. J Clin Endocrinol Metab 1979; 48:946-954.
54. Polonsky K, Lucinio-Paixao J, Given BD, et al. Use of biosynthetic human C-peptide in the measurement of insulin secretion rates in normal volunteers and type 1 diabetic patients. J Clin Invest 1986; 77:98-105.
55. Kahn SE, Beard JC, Schwartz MW, et al. Increased β-cell secretory capacity as mechanism for islet adaptation to nicotinic-acid-induced insulin resistance. Diabetes 1989; 38:562-568.
56. Weyer C, Bogardus C, Mott DM, Pratley RE. The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus. J Clin Invest 1999; 104:787-794.
57. Kahn SE, Prigeon RL, McCulloch DK, et al. Quantification of the relationship between insulin sensitivity and β-cell function in human subjects: evidence for a hyperbolic function. Diabetes 1993; 42:1663-1672.
58. Howard G, O'Leary DH, Zaccaro D, et al. Insulin sensitivity and atherosclerosis: the Insulin Resistance Atherosclerosis Study (IRAS) Investigators. Circulation 1996; 93:1809-1817.
59. Elbein SC, Hasstedt SJ, Wegner K, Kahn SE. Heritability of pancreatic β-cell function among nondiabetic members of Caucasian familial type 2 diabetic kindreds. J Clin Endocrinol Metab 1999; 84:1398-1403.